Abstract
AbstractMutations inINPPL1, the gene coding for SH2 Domain-Containing Inositol 5’-Phosphatase 2 (SHIP2), cause Opsismodysplasia, a severe chondrodysplasia characterized by delayed bone maturation. The mechanism by which the loss of an inositol phosphatase causes a major skeletal developmental defect is unclear. To investigate the role of SHIP2 in mineralization, theINPPL1gene was deletedin vitroin chondrocyte and osteoblast differentiation models and the effect of the loss of SHIP2 on cell differentiation, subsequent mineralization, and on actin cytoskeleton formation was investigated. The loss of SHIP2 does not impact differentiation but, consistent with the disease phenotype, induces a significant reduction in extracellular matrix mineralization in both cell types. Absence of SHIP2 also altered the actin cytoskeleton to increase cell adhesion and focal adhesion formation. Furthermore, inhibition of actin polymerization in SHIP2-deficient cells rescued the mineralization phenotype. RhoA/ROCK, Cdc42 and Rac1 are the three main RhoGTPases responsible for actin cytoskeleton regulation in bone cells. Specific inhibitors of these RhoGTPases were used to determine the pathways involved in SHIP2-mediated mineralization. Since only the ROCK pathway inhibitor rescued the mineralization phenotype, it is concluded that SHIP2 regulates actin cytoskeleton remodeling and consequently extracellular matrix mineralization by inhibiting the RhoA/ROCK pathway.
Publisher
Cold Spring Harbor Laboratory
Reference50 articles.
1. Ando, K. , Erneux, C. , Homa, M. , Houben, S. , de Fisenne, M. A. , Brion, J. P. , and Leroy, K. Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer’s Disease.
2. Kerr, W. G. , Pedicone, C. , Dormann, S. , Pacherille, A. , and Chisholm, J. D. Small molecule targeting of SHIP1 and SHIP2.
3. Targeting SHIP1 and SHIP2 in Cancer
4. Whole-Genome Analysis Reveals that Mutations in Inositol Polyphosphate Phosphatase-like 1 Cause Opsismodysplasia
5. Exome Sequencing Identifies INPPL1 Mutations as a Cause of Opsismodysplasia